Watch now<\/a><\/p>\n\n\n\n

Webinar Description:<\/strong><\/p>\n\n\n\n

RNA Sequencing (RNA-seq) is an increasingly popular technology for biomarker discovery in cancer research. High-throughput RNA-seq produces large quantities of complex data that require computational bioinformatics pipelines to enable interpretation.<\/p>\n\n\n\n

Almac Diagnostic Services has developed a unique reporting solution called clara^{T<\/sup>* \u2013 A unique software-driven solution, classifying biologically relevant gene expression signatures into a comprehensive, easy-to-interpret report.<\/p>\n\n\n\n}

The clara^{T<\/sup>report outputs include the entire study cohort and individual sample reports from Almac internally developed bioinformatics pipelines. claraT<\/sup> reports on relevant public and proprietary gene expression signatures as well as single gene targets within all 10 Hallmarks of Cancer using Almac\u2019s optimised RNA exome panel.<\/p>\n\n\n\n}

What you will learn: <\/strong><\/p>\n\n\n\n

• How the clara^{T<\/sup> report was created<\/li>}
• The structure and layout of the clara^{T<\/sup> report<\/li>}
• A detailed walk through of both the cohort and sample summaries<\/li>
• How the clara^{T<\/sup> report can support biomarker discovery and aid novel cancer research findings<\/li>}
• Case study: Utilising clara^{T<\/sup> in a real world gene expression dataset for malignant melanoma<\/li><\/ul>\n\n\n\n}

  Click here to download more information<\/a><\/p>\n\n\n\n

  Presented by:<\/strong><\/p>\n\n\n\n

  Dr. Gemma Logan, Senior Product Manager, Almac Diagnostic Services.<\/strong> <\/p>\n\n\n\n

  <\/div>\n